Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging (2024)

1. Olton DS, Becker JT, Handelmann GE. Hippocampus, space, and memory. Behav and Brain Sci. 1979;2:313–322. [Google Scholar]

2. Squire LR. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol Rev. 1992;99:195–231. [PubMed] [Google Scholar]

3. Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR, Sauer H, Gaser C, Smesny S. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study. Schizophrenia Res. 2015;161:169–176. [PubMed] [Google Scholar]

4. Singh R, Meier TB, Kuplicki R, Savitz J, Mukai I, Cavanagh L, Allen T, Teague TK, Nerio C, Polanski D, Bellgowan PSF. Relationship of Collegiate Football Experience and Concussion With Hippocampal Volume and Cognitive Outcomes. JAMA. 2014;311:1883. [PubMed] [Google Scholar]

5. Wang Z, Neylan TC, Mueller SG, Lenoci M, Truran D, Marmar CR, Weiner MW, Schuff N. Magnetic Resonance Imaging of Hippocampal Subfields in Posttraumatic Stress Disorder. Arch Gen Psychiatry. 2010;67:296. [PMC free article] [PubMed] [Google Scholar]

6. Wisse LEM, Biessels GJ, Stegenga BT, Kooistra M, van der Veen PH, Zwanenburg JJM, van der Graaf Y, Geerlings MI. Major depressive episodes over the course of 7 years and hippocampal subfield volumes at 7 tesla MRI: The PREDICT-MR study. J of Affective Dis. 2015;175:1–7. [PubMed] [Google Scholar]

7. Xu Y, Jack CR, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, Boeve BF, Tangalos RG, Petersen RC. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760–1767. [PubMed] [Google Scholar]

8. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143–1153. [PubMed] [Google Scholar]

9. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58:1188–1196. [PubMed] [Google Scholar]

10. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissinen A, Helkala E-L, Vainio P, Vanninen R, Partanen K, Soininen H. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol. of Aging. 2004;25:303–310. [PubMed] [Google Scholar]

11. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991;41:51–51. [PubMed] [Google Scholar]

12. Ringman JM, Pope W, Salamon N. Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer’s disease. J Neurol. 2010;257:839–842. [PMC free article] [PubMed] [Google Scholar]

13. Farid N, Girard HM, Kemmotsu N, Smith ME, Magda SW, Lim WY, Lee RR, McDonald CR. Temporal Lobe Epilepsy: Quantitative MR Volumetry in Detection of Hippocampal Atrophy. Radiology. 2012;264:542–550. [PMC free article] [PubMed] [Google Scholar]

14. Varon D, Barker W, Loewenstein D, Greig M, Bohorquez A, Santos I, Shen Q, Harper M, Vallejo-Luces T, Duara R Alzheimer's Disease Neuroimaging I. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome. Int J Geriatr Psychiatry. 2015;30:192–200. [PubMed] [Google Scholar]

15. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819–828. [PMC free article] [PubMed] [Google Scholar]

16. Cherbuin N, Reglade-Meslin C, Kumar R, Jacomb P, Easteal S, Christensen H, Sachdev P, Anstey KJ. Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study. Dement Geriatr Cogn Disord. 2009;28:47–55. [PubMed] [Google Scholar]

17. Boyle CP, Raji CA, Erickson KI, Lopez OL, Becker JT, Gach HM, Longstreth WT, Teverovskiy L, Kuller LH, Carmichael OT, Thompson PM. Physical activity, body mass index, and brain atrophy in Alzheimer's disease. Neurobiol. of Aging. 2015;36:S194–S202. [PMC free article] [PubMed] [Google Scholar]

18. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol. 2012 [PubMed] [Google Scholar]

19. Raji CA, Erickson KI, Lopez OL, Kuller LH, Gach HM, Thompson PM, Riverol M, Becker JT. Regular Fish Consumption and Age-Related Brain Gray Matter Loss. Amer J of Preventive Med. 2014;47:444–451. [PMC free article] [PubMed] [Google Scholar]

20. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, Thompson PM. Brain structure and obesity. Hum Brain Mapp. 2010;31:353–364. [PMC free article] [PubMed] [Google Scholar]

21. Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, Gach HM, Thompson PM, Ho AJ, Kuller LH. Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology. 2010;75:1415–1422. [PMC free article] [PubMed] [Google Scholar]

22. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF. Exercise training increases size of hippocampus and improves memory. PNAS. 2011;108:3017–3022. [PMC free article] [PubMed] [Google Scholar]

23. Raji CA, Wei SH, Bredesen DE, Moylan S, Law M, Small GW, Thompson PM, Friedlander RM, Silverman DH, Baune BT, Hoang TA, Salamon N, Vernooij MW. Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline. AJRN. 2015 In Press. [PMC free article] [PubMed] [Google Scholar]

24. Varma VR, Chuang YF, Harris GC, Tan EJ, Carlson MC. Low-intensity daily walking activity is associated with hippocampal volume in older adults. Hippocampus. 2015;25:605–615. [PMC free article] [PubMed] [Google Scholar]

25. Association As 2015 Alzheimer's Disease Facts and Figures. Alz & Dem. 11 [PubMed] [Google Scholar]

26. Strain JF, Womack KB, Didehbani N, et al. IMaging correlates of memory and concussion history in retired national football league athletes. JAMA Neurol. 2015 [PMC free article] [PubMed] [Google Scholar]

27. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolesz FA, McCarley RW, Pitman RK. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol. Psychiatry. 1996;40:1091–1099. [PMC free article] [PubMed] [Google Scholar]

28. Wignall EL, Dickson JM, Vaughan P, Farrow TFD, Wilkinson ID, Hunter MD, Woodruff PWR. Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder. Biol. Psychiatry. 2004;56:832–836. [PubMed] [Google Scholar]

29. Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ. Hippocampal volume and the rapid antidepressant effect of ketamine. J. of Psychopharmacology. 2014 [PMC free article] [PubMed] [Google Scholar]

30. Ishiwata A, Mizumura S, Mishina M, Yamazaki M, Katayama Y. The Potentially Protective Effect of Donepezil in Alzheimer's Disease. Dement Geriatr Cogn Disord. 2014;38:170–177. [PubMed] [Google Scholar]

31. Redlich R, Almeida JJR, Grotegerd D, Opel N, Kugel H, Heindel W, Arolt V, Phillips ML, Dannlowski U. Brain Morphometric Biomarkers Distinguishing Unipolar and Bipolar Depression. JAMA Psychiatry. 2014;71:1222. [PMC free article] [PubMed] [Google Scholar]

32. Haukvik UK, Westlye LT, Mørch-Johnsen L, Jørgensen KN, Lange EH, Dale AM, Melle I, Andreassen OA, Agartz I. In Vivo Hippocampal Subfield Volumes in Schizophrenia and Bipolar Disorder. Biol. Psychiatry. 2015;77:581–588. [PubMed] [Google Scholar]

33. Benedict RHB, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J. Neurol, Neurosurg & Psychiatry. 2009;80:201–206. [PubMed] [Google Scholar]

34. Moran NF, Lemieux L, Kitchen ND, Fish DR, Shorvon SD. Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain. 2001;124:167–175. [PubMed] [Google Scholar]

35. Mueller SG, Laxer KD, Barakos J, Cheong I, Garcia P, Weiner MW. Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: Preliminary results. Epilepsia. 2009;50:1474–1483. [PMC free article] [PubMed] [Google Scholar]

36. de Lanerolle NC, Lee TS. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav. 2005;7:190–203. [PubMed] [Google Scholar]

37. Téllez-Zenteno JF, Hernández-Ronquillo L. A Review of the Epidemiology of Temporal Lobe Epilepsy. Epilepsy Res. and Treatment. 2012;2012:1–5. [PMC free article] [PubMed] [Google Scholar]

38. Ver Hoef LW, Williams FB, Kennedy RE, Szaflarski JP, Knowlton RC. Predictive value of hippocampal internal architecture asymmetry in temporal lobe epilepsy. Epilepsy Res. 2013;106:155–163. [PMC free article] [PubMed] [Google Scholar]

39. Rodrigue KM. Shrinkage of the Entorhinal Cortex over Five Years Predicts Memory Performance in Healthy Adults. J of Neurosci. 2004;24:956–963. [PMC free article] [PubMed] [Google Scholar]

40. Ezekiel F, Chao L, Kornak J, Du AT, Cardenas V, Truran D, Jagust W, Chui H, Miller B, Yaffe K, Schuff N, Weiner M. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord. 2004;18:196–201. [PMC free article] [PubMed] [Google Scholar]

41. Boccardi M, Bocchetta M, Apostolova LG, Preboske G, Robitaille N, Pasqualetti P, Collins LD, duch*esne S, Jack CR, Frisoni GB. Establishing Magnetic Resonance Images Orientation for the EADC-ADNI Manual Hippocampal Segmentation Protocol. J Neuroimaging. 2013;24:509–514. [PubMed] [Google Scholar]

42. Bocchetta M, Boccardi M, Ganzola R, Apostolova LG, Preboske G, Wolf D, Ferrari C, Pasqualetti P, Robitaille N, duch*esne S, Jack CR, Frisoni GB. Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project. Alzheimer's & Dementia. 2015;11:151.e155–160.e155. [PubMed] [Google Scholar]

43. Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamash*ta F, Asada T, Iwabuchi S, Samejima H. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Letters. 2005;382:269–274. [PubMed] [Google Scholar]

44. Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol. of Aging. 2009;30:1711–1723. [PMC free article] [PubMed] [Google Scholar]

45. Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, DeCarli C, Dubois B, duch*esne S, Fox NC, Frisoni GB, Hampel H, Hill DLG, Johnson K, Mangin J-F, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease. Alz & Dement. 2011;7:474.e474–485.e474. [PMC free article] [PubMed] [Google Scholar]

46. Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, duch*esne S, Jack CR, Jr, Frisoni GB Segmentation E-AWGoTHPfMH, for the Alzheimer's Disease Neuroimaging I. Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alz & Dement. 2015;11:184–194. [PubMed] [Google Scholar]

47. duch*esne S, Valdivia F, Robitaille N, Mouiha A, Valdivia FA, Bocchetta M, Apostolova LG, Ganzola R, Preboske G, Wolf D, Boccardi M, Jack CR, Jr, Frisoni GB Segmentation E-AWGoTHPfMH, for the Alzheimer's Disease Neuroimaging I. Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project. Alz & Dement. 2015;11:161–174. [PubMed] [Google Scholar]

48. Frisoni GB, Jack CR, Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehericy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, duch*esne S, Duvernoy H, Boccardi M Volumetry E-AWGoTHPfMH, for the Alzheimer's Disease Neuroimaging I. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity. Alz & Dement. 2015;11:111–125. [PMC free article] [PubMed] [Google Scholar]

49. Boccardi M, Bocchetta M, Morency FC, Collins DL, Nishikawa M, Ganzola R, Grothe MJ, Wolf D, Redolfi A, Pievani M, Antelmi L, Fellgiebel A, Matsuda H, Teipel S, duch*esne S, Jack CR, Jr, Frisoni GB Segmentation E-AWGoTHPfMH, for the Alzheimer's Disease Neuroimaging I. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alz & Dement. 2015;11:175–183. [PubMed] [Google Scholar]

50. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, deToledo-Morrell L, Killiany RJ, Lehericy S, Pantel J, Pruessner JC, Soininen H, Watson C, duch*esne S, Jack CR, Jr, Frisoni GB. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis. 2011;26(Suppl 3):61–75. [PMC free article] [PubMed] [Google Scholar]

51. Jack CR, Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, J LW, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27:685–691. [PMC free article] [PubMed] [Google Scholar]

52. Ahdidan J, Hviid LB, Chakravarty MM, Ravnkilde B, Rosenberg R, Rodell A, Stødkilde-Jørgensen H, Videbech P. Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder. Acta Psychiatrica Scandinavica. 2011;123:211–219. [PubMed] [Google Scholar]

53. Dice LR. Measures of the Amount of Ecologic Association Between Species. Ecology. 1945;26:297. [Google Scholar]

54. Shen Q. Volumetric Analysis of Brain MRI for Alzheimer-s Disease. Open Access Dissertations. 2011 Paper 526. [Google Scholar]

55. Zou KH, Warfield SK, Bharatha A, Tempany CMC, Kaus MR, Haker SJ, Wells WM, Jolesz FA, Kikinis R. Statistical validation of image segmentation quality based on a spatial overlap index1. Acad Radiol. 2004;11:178–189. [PMC free article] [PubMed] [Google Scholar]

56. Tustison NJ, Avants BB, Cook PA, Yuanjie Z, Egan A, Yushkevich PA, Gee JC. N4ITK: Improved N3 Bias Correction. IEEE Transactions on Medical Imaging. 2010;29:1310–1320. [PMC free article] [PubMed] [Google Scholar]

57. Carmichael OT, Aizenstein HA, Davis SW, Becker JT, Thompson PM, Meltzer CC, Liu Y. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. NeuroImage. 2005;27:979–990. [PMC free article] [PubMed] [Google Scholar]

58. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–355. [PubMed] [Google Scholar]

59. Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image and Vision Comput. 2001;19:25–31. [Google Scholar]

60. Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, Fox NC, Ourselin S. Fast free-form deformation using graphics processing units. Computer Methods and Programs in Biomedicine. 2010;98:278–284. [PubMed] [Google Scholar]

61. Winston GP, Cardoso MJ, Williams EJ, Burdett JL, Bartlett PA, Espak M, Behr C, Duncan JS, Ourselin S. Automated hippocampal segmentation in patients with epilepsy: available free online. Epilepsia. 2013;54:2166–2173. [PMC free article] [PubMed] [Google Scholar]

62. Jack CR, Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW Alzheimer's Disease Neuroimaging I. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alz & Dement. 2010;6:212–220. [PMC free article] [PubMed] [Google Scholar]

63. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988. [Google Scholar]

64. Ochs AL, Ross DE, Zannoni MD, Abildskov TJ, Bigler ED. Comparison of Automated Brain Volume Measures obtained with NeuroQuant(R) and FreeSurfer. J Neuroimaging. 2015;25:721–727. [PubMed] [Google Scholar]

65. Lehmann M, Douiri A, Kim LG, Modat M, Chan D, Ourselin S, Barnes J, Fox NC. Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements. Neuroimage. 2010;49:2264–2274. [PubMed] [Google Scholar]

66. Sanchez-Benavides G, Gomez-Anson B, Sainz A, Vives Y, Delfino M, Pena-Casanova J. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects. Psychiatry Res. 2010;181:219–225. [PubMed] [Google Scholar]

67. Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H Alzheimer's Disease Neuroimaging I. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. Neuroimage. 2014;92:169–181. [PubMed] [Google Scholar]

68. Kirson N, Hunter C, Desai U, Cummings A, San Roman A, Faries D, Hardwick C, Birnbaum H. Excess costs associated with misdiagnosis of Alzheimer's disease among U.S. Medicare beneficiaries with vascular dementia or Parkinson's disease. Alzh & Dement. 2013;9:P845–P846. [Google Scholar]

69. Brewer JB. Fully-Automated Volumetric MRI with Normative Ranges: Translation to Clinical Practice. Behav Neurol. 2009;21:21–28. [PMC free article] [PubMed] [Google Scholar]

70. Ramani A, Jensen JH, Helpern JA. Quantitative MR Imaging in Alzheimer Disease 1. Radiology. 2006;241:26–44. [PubMed] [Google Scholar]

71. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G-F, Estrada S, Austin B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurol. 2004;55:306–319. [PubMed] [Google Scholar]

74. Desikan RS, Rafii MS, Brewer JB, Hess CP. An expanded role for neuroimaging in the evaluation of memory impairment. AJNR. 2013;34:2075–2082. [PMC free article] [PubMed] [Google Scholar]

75. Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, Ortega BN, Zaiko YV, Roach EL, Korgaonkar MS, Grieve SM, Galatzer-Levy I, Fox PT, Etkin A. Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry. 2015;72:305–315. [PMC free article] [PubMed] [Google Scholar]

76. Perez-Miralles FC, Sastre-Garriga J, Vidal-Jordana A, Rio J, Auger C, Pareto D, Tintore M, Rovira A, Montalban X. Predictive value of early brain atrophy on response in patients treated with interferon beta. Neurol Neuroimmunol Neuroinflamm. 2015;2:e132. [PMC free article] [PubMed] [Google Scholar]